Xiaoting Gu

机构：Nankai University, Tianjin International Joint Academy of Biomedicine, Tianjin Stomatological Hospital, State Key Laboratory of Medicinal Chemical Biology · ORCID：0000-0002-9236-5941

发表论文 26 篇 · 总被引 302 次 · h-index 9

代表论文

• PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling (2022 · Science Advances · 被引 130)
• FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis (2023 · International Journal of Biological Sciences · 被引 25)
• Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways (2022 · Frontiers in Pharmacology · 被引 20)
• Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarization (2024 · International Immunopharmacology · 被引 14)
• Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis (2023 · European Journal of Pharmacology · 被引 14)
• Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation (2024 · International Immunopharmacology · 被引 12)